InvestorsHub Logo
icon url

willyw

08/05/21 1:37 PM

#1993 RE: vinmantoo #1992

I'm sure they will talk about it in today's CC.

It strikes me that Pfizer is a huge company and has a head start; but not by much.

Enanta has a strong history and record with anti-virals; particularly with protease inhibitors.

I was anxious for ENTA to develop a compound. Did Pfizer's haste to create a PI create a best in class PI? ENTA may have a better solution than the goliath company; they have anti-viral expertise, created the best in class PI for HCV, and may have demonstrated the same in RSV and HBV.

It would seem that covid isn't going away.
There is talk about the virus evading vaccines.
This looks encouraging to me.